Also trades as: 1302.HK (HKSE) · $vol 4M
LFTSF OTC
LifeTech Scientific Corporation
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -31.3%
$0.23
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1.3B
+2.9% ▲
5Y CAGR: +14.3%
Gross Profit
$981M
-1.4% ▼
5Y CAGR: +12.9%
Operating Income
$186M
-51.4% ▼
5Y CAGR: -0.3%
Net Income
$222M
-15.5% ▼
5Y CAGR: +11.5%
EPS (Diluted)
$0.05
-13.9% ▼
5Y CAGR: +10.3%
EBITDA
$289M
+14.0% ▲
5Y CAGR: +3.2%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $642M | $925M | $1.1B | $1.3B | $1.3B |
| YoY Growth | -4.0% | +44.1% | +18.6% | +15.5% | +2.9% |
| Cost of Revenue | $129M | $178M | $223M | $272M | $322M |
| Gross Profit | $513M | $748M | $874M | $996M | $981M |
| Gross Margin | 79.9% | 80.8% | 79.6% | 78.6% | 75.3% |
| R&D Expenses | $167M | $146M | $208M | $298M | $303M |
| SG&A Expenses | $320M | $291M | $348M | $415M | $504M |
| Operating Expenses | $249M | $421M | $498M | $612M | $795M |
| Operating Income | $264M | $329M | $376M | $383M | $186M |
| Operating Margin | 41.2% | 35.5% | 34.3% | 30.2% | 14.3% |
| Interest Expense | $26M | $3M | $632K | $722K | $2M |
| Income Before Tax | $243M | $333M | $378M | $176M | $199M |
| Tax Expense | $36M | $50M | $59M | $68M | $31M |
| Net Income | $216M | $292M | $325M | $263M | $222M |
| Net Margin | 33.6% | 31.6% | 29.6% | 20.8% | 17.1% |
| EPS (Diluted) | $0.05 | $0.06 | $0.07 | $0.06 | $0.05 |
| EBITDA | $314M | $398M | $446M | $253M | $289M |
| Shares Outstanding | 4.39B | 4.56B | 4.41B | 4.45B | 4.39B |